Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
Hemodialysis International. International Symposium on Home Hemodialysis
|
October 5, 2020
Fibroblast growth factor 23 as a risk factor for cardiovascular events and mortality in patients in the EVOLVE trial
Geoffrey A Block, Glenn M Chertow, Kerry Cooper, et al.
Blood
|
December 31, 2010
An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia
Mark D Danese, Robert I Griffiths, Michelle Gleeson, et al.
Leukemia & Lymphoma
|
January 12, 2019
Treatment patterns, survival, and hospitalization in adult patients with acute lymphoblastic leukemia: an observational cohort study using SEER Medicare data
Mark D Danese, Aaron Katz, Karynsa Cetin, et al.
American Journal of Nephrology
|
September 23, 2020
Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients
Mark D Danese, Deborah Lubeck, Vasily Belozeroff, et al.
Advances in Therapy
|
April 17, 2022
Association Between Granulocyte Colony-Stimulating Factor (G-CSF) Use and Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Among Elderly Patients with Breast, Lung, or Prostate Cancer
Mark D Danese, Jennifer Schenfeld, Jaime Shaw, et al.
Recenti Progressi in Medicina
|
November 1, 1989
Circadian rhythmicity of plasma amino acid variations in healthy subjects
O Riggio, M Merli, U Pièche, et al.
Kidney International
|
August 31, 2006
Catheter use is high even among hemodialysis patients with a fistula or graft
M D Danese, Z Liu, R I Griffiths, et al.
Hormone Research
|
March 23, 2002
Age-related prevalence of platelet-associated immunoglobulins G in nonthrombocytopenic patients with autoimmune thyroid disease and autoimmune polyglandular syndrome
L Gargano, D Mentuccia, L Conti, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
January 20, 2016
Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011
Deborah P Lubeck, Mark D Danese, Jennifer Duryea, et al.
BMJ Open
|
May 13, 2017
Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study
Mark D Danese, Michelle Gleeson, Lucie Kutikova, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
Hemodialysis International. International Symposium on Home Hemodialysis
|
October 5, 2020
Fibroblast growth factor 23 as a risk factor for cardiovascular events and mortality in patients in the EVOLVE trial
Geoffrey A Block, Glenn M Chertow, Kerry Cooper, et al.
Blood
|
December 31, 2010
An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia
Mark D Danese, Robert I Griffiths, Michelle Gleeson, et al.
Leukemia & Lymphoma
|
January 12, 2019
Treatment patterns, survival, and hospitalization in adult patients with acute lymphoblastic leukemia: an observational cohort study using SEER Medicare data
Mark D Danese, Aaron Katz, Karynsa Cetin, et al.
American Journal of Nephrology
|
September 23, 2020
Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients
Mark D Danese, Deborah Lubeck, Vasily Belozeroff, et al.
Advances in Therapy
|
April 17, 2022
Association Between Granulocyte Colony-Stimulating Factor (G-CSF) Use and Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Among Elderly Patients with Breast, Lung, or Prostate Cancer
Mark D Danese, Jennifer Schenfeld, Jaime Shaw, et al.
Recenti Progressi in Medicina
|
November 1, 1989
Circadian rhythmicity of plasma amino acid variations in healthy subjects
O Riggio, M Merli, U Pièche, et al.
Kidney International
|
August 31, 2006
Catheter use is high even among hemodialysis patients with a fistula or graft
M D Danese, Z Liu, R I Griffiths, et al.
Hormone Research
|
March 23, 2002
Age-related prevalence of platelet-associated immunoglobulins G in nonthrombocytopenic patients with autoimmune thyroid disease and autoimmune polyglandular syndrome
L Gargano, D Mentuccia, L Conti, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
January 20, 2016
Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011
Deborah P Lubeck, Mark D Danese, Jennifer Duryea, et al.
BMJ Open
|
May 13, 2017
Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study
Mark D Danese, Michelle Gleeson, Lucie Kutikova, et al.
Page
of 9